logo
Plus   Neg
Share
Email

Medtronic Canada Receives Health Canada Licence For Micra AV - Quick Facts

Medtronic Canada ULC, a subsidiary of Medtronic plc (MDT) announced Monday that it has received a Health Canada licence for Micra AV, the world's smallest pacemaker with atrioventricular (AV) synchrony.

Micra AV is indicated for the treatment of patients with AV block, a condition in which the electrical connection between the chambers of the heart (the atria and the ventricle) is impaired.

Medtronic's technology is the first and currently the only Health Canada-licensed leadless pacemaker portfolio, now expanding the range of eligible Canadian patients that can be implanted.

Micra AV has several additional features, including internal atrial sensing algorithms which detect cardiac movement, allowing the device to adjust pacing in the ventricle to coordinate with the atrium, providing "AV synchronous" pacing therapy to patients with AV block.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The Inter-American Development Bank and Citi Innovation Labs have successfully completed a proof-of-concept to make cross-border payments from the U.S. to countries in Latin America and the Caribbean, using blockchain and tokenized money. The platform provided full traceability of the transactions, exchange rates, and fees on blockchain. Australian competition regulator said the country's Federal Court found that Google and its Australian arm misled users about the collection and use of personal location data. The data was collected through Android mobile devices between January 2017 and December 2018. This is said to be the world-first enforcement action brought by the Australian Competition and Consumer Commission or ACCC. Morgan Stanley (MS) reported a first-quarter profit that more than doubled from last year, reflecting strong performance across all of its business segment. Net revenues for the quarter grew 61 percent from the previous year. Quarterly adjusted earnings per share beat analysts' estimates.
Follow RTT